Nebenwirkungen · Entresto
Entresto 6 mg/6 mg granules in capsules for opening Entresto 15 mg/16 mg granules in capsules for opening · Abschnitt 4.8 · PDF-Seite 31
HOS-134425 · Präparat HOS-097566
System organ class Preferred term Frequency category Blood and lymphatic system Anaemia Common disorders Immune system disorders Hypersensitivity Uncommon Metabolism and nutrition Hyperkalaemia* Very common disorders Hypokalaemia Common Hypoglycaemia Common Hyponatraemia Uncommon Psychiatric disorders Hallucinations** Rare Sleep disorders Rare Paranoia Very rare Nervous system disorders Dizziness Common Headache Common Syncope Common Dizziness postural Uncommon Myoclonus Not known Ear and labyrinth disorders Vertigo Common Vascular disorders Hypotension* Very common Orthostatic hypotension Common Respiratory, thoracic and Cough Common mediastinal disorders Gastrointestinal disorders Diarrhoea Common Nausea Common Gastritis Common Intestinal angioedema Very rare Skin and subcutaneous tissue Pruritus Uncommon disorders Rash Uncommon Angioedema* Uncommon Renal and urinary disorders Renal impairment* Very common Renal failure (renal failure, Common acute renal failure) General disorders and Fatigue Common administration site conditions Asthenia Common *See description of selected adverse reactions. **Including auditory and visual hallucinations
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-01-13T10:33:00Z · SHA-256 63effd0dd78bf1b11f8cfe5ae77efc68b2653de13ba467bbf4e48289e340b97e · Passage 2641359950e95a8b8e62f0ddf3ceff2372cc9ec0475f58bf4e45b1c436b41ca0 · Zeichen 862–3656 im Abschnitt